Hachisuga K, Hidaka N, Fujita Y, et al: Can we predict neonatal thrombocytopenia in ofspring of women with idiopathic thrombocytopenic purpura? Blood 49(4):259,o2014
Hackney ON, Knudtson E], Rossi KQ, et al: Management of pregnancies complicated by anti-c isoimmunization. Obstet Gynecol 103:24, 2004 Heinonen S, Ruynamen M, Kirkinen P: Etiology and outcome of second trimes ter nonimmunological fetal hydrops. Scando] Obstet Gynecol 79: 15, 2000
Howard H, Mardew V, McFadyen I, et al: Consequences for fetus and neonate of maternal red cell allo-immunization. Arch Dis Child Fetal Neonat Ed 78:F62, 1998
Johnson ]A, MacDonald K, Clarke G, et al: No. 343-Routine non-invasive prenatal prediction of fetal RHO genotype in Canada: the time is here. ] Obstet Gynaecol Can 39(5):366, 2017
Kamphuis MM, Paridaans N, Porcelijn L, et al: Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. B]OG 117(1o1):1335,o2010
Kleihauer B, Braun H, Betke K: Demonstration of fetal hemoglobin in erythrocytes of a blood smear. Klin Wochenschr 35(12):637, 1957
Knight M, Pierce M, Allen 0, et al: The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources. Br] HaematoIo152(4):460, 2011 Koelewijn ]M, Vrijkotte TG, van der Schoot CE, et al: Efect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 48:941,o2008
Lazar L, Harmath AG, Ban Z, et al: Detection of maternal deoxyribonucleic acid in peripheral blood of premature and mature newborn infants. Prenat Diagn 26(2):168, 2006
Liao C, Weio], Li Q, et al: Nonimmune hydrops fetal is diagnosed during the second half of pregnancy in Southern China. Fetal Diagn Ther 22(4):302,o2007 Liley A W: Liquor amnii analysis in management of pregnancy complicated by rhesus sensitization. Amo] Obstet GynecoIo82:1359, 1961 Lindenburg I, van Kamp I, van Zwet E, et al: Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation. B]OG 120:847,o2013
Lindenburg IT, Smits-Wintjens VE, van Klink ]M, et al: Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Amo] Obstet Gynecol 206:o141. e1,o2012
Livingston ]C, Malik M, Crombleholme TM, et al: Mirror syndrome: a novel approach to therapy with fetal peritoneal-amniotic shunt. Obstet Gynecol 110(2 Pt 2):540,o2007